IPAR
Inter Parfums, Inc.
Data as of 2026-07-21
Company attributes
Price
Interactive 5-year price history chart for IPAR. Latest close $122.82.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency82ExceptionalConsumer Staples median (n=76) 50
- ValuePrice vs fundamentals45AverageConsumer Staples median (n=76) 53
- GrowthRevenue & earnings trajectory80ExceptionalConsumer Staples median (n=76) 48
- MomentumRecent price strength53AverageConsumer Staples median (n=76) 43
- HealthBalance sheet & solvency74ExceptionalConsumer Staples median (n=76) 40
- ProfitabilityROE, ROA, ROIC83ExceptionalConsumer Staples median (n=76) 50
- TechnicalTrend & volatility signals61StrongConsumer Staples median (n=76) 52
- RiskVolatility & drawdown profile45AverageConsumer Staples median (n=76) 52
Pillars not shown: Sentiment, ML (Phase 5+).
Recent regulatory events
- Auditor change (8-K Item 4.01)AnnotateView filing
Latest 8-K: 2026-05-13
Risk Summary
Low- Restatement history (10-K/A, 5y)[restatement_history]
- Late-filing notification (Form 12b-25, 1y)[late_filing_notification]
Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.
Fair price check
6 different valuation methods each estimate what IPARshould be worth, then we compare to today's price.
- P/B multiplesUndervaluedthinks it's a bargain — estimates $149.20, about 21% above today
- EV/EBITDAFairthinks it's fairly priced — estimates $112.48, about 8% below today
- P/E multiplesOvervaluedthinks it's expensive — estimates $108.55, about 12% below today
- Graham (defensive)Overvaluedthinks it's expensive — estimates $44.66, about 64% below today
- DCF (2-stage)Overvaluedthinks it's expensive — estimates $35.51, about 71% below today
- Residual IncomeOvervaluedthinks it's expensive — estimates $29.95, about 76% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $76.60
- Margin of safety(vs fair value)
- -60.3%
- Max (ex-outliers)
- $149.20
- Tangible BVPS
- $17.60
- Restatement history
- Late-filing notification
Median of all applicable methods (current price $122.82). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $3.93B |
| Revenue (TTM) | $1.49B |
| Net income (TTM) | $209.44M |
| Operating cash flow (TTM) | $222.34M |
| CapEx (TTM) | $24.34M |
| Free cash flow (TTM)CFO − CapEx | $198.01M |
| Total assets | $1.54B |
| Total liabilities | N/A |
| Stockholders' equity | $881.64M |
| Cash & equivalents | $79.76M |
| Shares outstanding | 32.03M |
| EPS (basic) | $6.54 |
| EPS (diluted) | $6.54 |
| P/E ratio (TTM) | 18.78 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-05-05
- Latest period end
- 2026-05-05
- Filing lag
- 77 days
- Missing metrics
- 2(total_liabilities, research_and_development)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.